Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 05 Aug 2026 for CytomX Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Alejandra Carvajal: trading record in brief
Alejandra Carvajal, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Momenta Pharmaceuticals Inc, Mersana Therapeutics, Inc. and CytomX Therapeutics, Inc. In total, 36 filings cover trades dated from 12 February 2019 to 3 August 2026.
On the market, this insider has only sold: 14 sales, €1.2M in total. Besides market trades, the filings include 4 share grants and 14 option exercises.
The newest entry dates from 5 August 2026: a share grant, in CytomX Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alejandra Carvajal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
100,000 shares0Common StockSEC:0001610717-26-000351:0
3,131 sharesCommon StockSEC:0001104659-26-001380:0
12,500 shares0Common StockSEC:0001104659-25-004591:0
2,500 shares0Common StockSEC:0001104659-25-004180:0
8,958 shares0Common StockSEC:0001104659-25-003876:0
50,000 shares0Common StockSEC:0001104659-24-106750:0
8,958 shares0Common StockSEC:0001104659-24-004543:0
13,250 shares0Common StockSEC:0001104659-23-052984:0
2,500 shares0Common StockSEC:0001104659-23-004736:0
13,250 shares0Common StockSEC:0001104659-22-052419:0
10 of 10 declarations
